Login
Boehringer Ingelheim
  • Therapeutic Area
    • Metabolic
    • Cardiovascular
      SPAF RWE Data Visualization Tool
    • Oncology
    • Respiratory
    • Specialty
  • Resources
  • Contact
Login

  • Add
    •  

    Resources

    VIDEOS

    What is the leading cause of death in patients with type 2 diabetes?

    01:25

    What is the leading cause of death in patients with type 2 diabetes?
    Are patients with T2D at elevated CV risk?

    02:11

    Are patients with T2D at elevated CV risk?
    What are the main considerations when choosing a medication for patients with type 2 diabetes?

    02:15

    What are the main considerations when choosing a medication for patients with type 2 diabetes?
    Asian CardioDiabetes Forum 2018 - Why is it important to examine evidence and not assume class effect by Prof. Richard Donnelly

    02:40

    Asian CardioDiabetes Forum 2018 - Why is it important to examine evidence and not assume class effect by Prof. Richard Donnelly
    Asian CardioDiabetes Forum 2018 - How have recent CV outcome trials influence clinical practice by Dr. Neale Cohen

    04:05

    Asian CardioDiabetes Forum 2018 - How have recent CV outcome trials influence clinical practice by Dr. Neale Cohen
    Asian CardioDiabetes Forum 2018 - The role of a cardiologist in diabetes management by Dr. Mansoor Husain

    04:12

    Asian CardioDiabetes Forum 2018 - The role of a cardiologist in diabetes management by Dr. Mansoor Husain
    Life happens: How emergency situations affect life of patients on OAC treatment

    00:53

    Life happens: How emergency situations affect life of patients on OAC treatment
    Life happens: Appendicitis is one of the most frequent abdominal surgical emergencies

    00:51

    Life happens: Appendicitis is one of the most frequent abdominal surgical emergencies
    Optimising outcomes in EGFR mutation-positive NSCLC: which tyrosine kinase inhibitor and when?

    01:24

    Optimising outcomes in EGFR mutation-positive NSCLC: which tyrosine kinase inhibitor and when?
    Early intervention to optimize lung function

    02:14

    Early intervention to optimize lung function
    New GOLD recommendations: ICS usage and eosinophil count as biomarker

    02:17

    New GOLD recommendations: ICS usage and eosinophil count as biomarker
    GOLD Update 2019 Guidelines

    08:30

    GOLD Update 2019 Guidelines
    New GOLD recommendations: Role of LABA/LAMA combinations in COPD.

    01:49

    New GOLD recommendations: Role of LABA/LAMA combinations in COPD
    Load more
    Close ×
    • Therapeutic Area
    • Metabolic
    • Cardiovascular
    • Oncology
    • Respiratory
    • Specialty
    • Resources
    • Videos
    • Clinical studies
    • Site map
    • Terms of use
    • Privacy
    • Contact
    • Change country

    Copyright © 2026 Boehringer Ingelheim (Thai) Ltd.
    All rights reserved. Use of this Site is subject to the Terms of Use and Privacy Statement.

    This website is intended for healthcare professionals in Thailand. The contents of this website are for information purposes only and are not intended to substitute for advice, treatment or recommendations of a healthcare professional. For your health concerns and other questions about symptoms, treatment or medication, consult a healthcare professional.